Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1989 1
1990 1
1992 2
1997 1
2001 3
2003 1
2004 2
2005 4
2006 2
2007 1
2008 2
2009 7
2010 3
2011 7
2012 6
2013 7
2014 3
2015 3
2016 6
2017 3
2018 2
2019 1
2020 6
2021 3
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Electroporation for therapeutic DNA vaccination in patients.
Sällberg M, Frelin L, Ahlén G, Sällberg-Chen M. Sällberg M, et al. Among authors: frelin l. Med Microbiol Immunol. 2015 Feb;204(1):131-5. doi: 10.1007/s00430-014-0384-8. Epub 2014 Dec 23. Med Microbiol Immunol. 2015. PMID: 25535102 Review.
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.
Burm R, Maravelia P, Ahlen G, Ciesek S, Caro Perez N, Pasetto A, Urban S, Van Houtte F, Verhoye L, Wedemeyer H, Johansson M, Frelin L, Sällberg M, Meuleman P. Burm R, et al. Among authors: frelin l. Gut. 2023 Jun;72(6):1186-1195. doi: 10.1136/gutjnl-2022-327216. Epub 2022 Aug 17. Gut. 2023. PMID: 35977815 Free PMC article.
Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease.
Yan J, Bangalore CR, Nikouyan N, Appelberg S, Silva DN, Yao H, Pasetto A, Weber F, Weber S, Larsson O, Höglund U, Bogdanovic G, Grabbe M, Aleman S, Szekely L, Szakos A, Tuvesson O, Gidlund EK, Cadossi M, Salati S, Tegel H, Hober S, Frelin L, Mirazimi A, Ahlén G, Sällberg M. Yan J, et al. Among authors: frelin l. Mol Ther. 2024 Feb 7;32(2):540-555. doi: 10.1016/j.ymthe.2024.01.007. Epub 2024 Jan 11. Mol Ther. 2024. PMID: 38213030 Free article.
Prospects and progress of DNA vaccines for treating hepatitis B.
Chen M, Jagya N, Bansal R, Frelin L, Sällberg M. Chen M, et al. Among authors: frelin l. Expert Rev Vaccines. 2016 May;15(5):629-40. doi: 10.1586/14760584.2016.1131615. Epub 2016 Jan 28. Expert Rev Vaccines. 2016. PMID: 26652035 Review.
A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T cells.
Appelberg S, Ahlén G, Yan J, Nikouyan N, Weber S, Larsson O, Höglund U, Aleman S, Weber F, Perlhamre E, Apro J, Gidlund EK, Tuvesson O, Salati S, Cadossi M, Tegel H, Hober S, Frelin L, Mirazimi A, Sällberg M. Appelberg S, et al. Among authors: frelin l. EMBO Mol Med. 2022 Oct 10;14(10):e15821. doi: 10.15252/emmm.202215821. Epub 2022 Sep 2. EMBO Mol Med. 2022. PMID: 35986481 Free PMC article.
The SARS-CoV-2 N Protein Is a Good Component in a Vaccine.
Ahlén G, Frelin L, Nikouyan N, Weber F, Höglund U, Larsson O, Westman M, Tuvesson O, Gidlund EK, Cadossi M, Appelberg S, Mirazimi A, Sällberg M; OPENCORONA Consortium. Ahlén G, et al. Among authors: frelin l. J Virol. 2020 Aug 31;94(18):e01279-20. doi: 10.1128/JVI.01279-20. Print 2020 Aug 31. J Virol. 2020. PMID: 32661140 Free PMC article. No abstract available.
Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.
Whitacre DC, Peters CJ, Sureau C, Nio K, Li F, Su L, Jones JE, Isogawa M, Sallberg M, Frelin L, Peterson DL, Milich DR. Whitacre DC, et al. Among authors: frelin l. Hum Vaccin Immunother. 2020;16(2):251-268. doi: 10.1080/21645515.2019.1689745. Epub 2019 Dec 6. Hum Vaccin Immunother. 2020. PMID: 31809638 Free PMC article.
71 results